| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35071-1mg | |||
| Carrier-Free | NBP2-35071-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52646-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47722-0.1mg | |||
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (HL-40) [NB500-408] - Immunohistochemistry staining of human small intestine (paraffin-embedded sections) with anti-HLA-DR/DP (HL-40).](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-HL-40-Immunohistochemistry-Paraffin-NB500-408-img0001.jpg "Immunohistochemistry-Paraffin: HLA DR/DP Antibody (HL-40) [NB500-408] - Immunohistochemistry staining of human small intestine (paraffin-embedded sections) with anti-HLA-DR/DP (HL-40).")
![Western Blot: CHD4 Antibody (BLR066G) [NBP2-77358] - Antibody: Rabbit anti-CHD4 recombinant monoclonal [BLR066G] (NBP2-77358). Secondary: HRP-conjugated goat anti-rabbit IgG.](http://images.novusbio.com/fullsize/CHD4-Antibody-BLR066G-Western-Blot-NBP2-77358-img0002.jpg "Western Blot: CHD4 Antibody (BLR066G) [NBP2-77358] - Antibody: Rabbit anti-CHD4 recombinant monoclonal [BLR066G] (NBP2-77358). Secondary: HRP-conjugated goat anti-rabbit IgG.")
![Western Blot: CHD4 Antibody (BLR066G) [NBP2-77358] - Antibody: Rabit anti-CHD4 recombinant monoclonal [BLR066G] (NBP2-77358). Secondary: HRP-conjugated goat anti-rabbit IgG. Lower Panel: Rabbit anti-GAPDH.](http://images.novusbio.com/fullsize/CHD4-Antibody-BLR066G-Western-Blot-NBP2-77358-img0001.jpg)
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: CHD4 Antibody (BLR066G) [NBP2-77358] - Detection of human CHD4 by WB of immunoprecipitates from HEK293T lysate. Antibodies: Rabbit anti-CHD4 recombinant monoclonal antibody [BLR066G] (NBP2-77358) and rabbit anti-CHD4 antibodies (NB100-57519, NB100-57520, NB100-57521).](http://images.novusbio.com/fullsize/CHD4-Antibody-BLR066G-Immunoprecipitation-NBP2-77358-img0003.jpg)
![Western Blot: ATF2 Antibody [NB100-835] - Human primary astrocyte lysates probed with ATF2 antibody. WB image submitted by a verified customer review.](http://images.novusbio.com/fullsize/ATF2-Antibody-Western-Blot-NB100-835-img0007.jpg "Western Blot: ATF2 Antibody [NB100-835] - Human primary astrocyte lysates probed with ATF2 antibody. WB image submitted by a verified customer review.")
![Western Blot: ATF2 Antibody [NB100-835] - Staining of HepG2 (A), K562 (B) and HeLa (C) nuclear lysates (35 ug protein in RIPA buffer). Antibody at 1 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/ATF2-Antibody-Western-Blot-NB100-835-img0006.jpg)
![Western Blot: HLA-DR Antibody (4Y9Y8) [NBP3-15337] - Analysis of extracts of Raji cells, using HLA-DR Rabbit mAb (NBP3-15337) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.](http://images.novusbio.com/fullsize/HLA-DR-Antibody-4Y9Y8-Western-Blot-NBP3-15337-img0002.jpg "Western Blot: HLA-DR Antibody (4Y9Y8) [NBP3-15337] - Analysis of extracts of Raji cells, using HLA-DR Rabbit mAb (NBP3-15337) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.")
![Immunohistochemistry: HLA-DR Antibody (4Y9Y8) [HLA-DR] - Immunohistochemistry analysis of HLA-DR in paraffin-embedded human tonsil tissue using HLA-DR Rabbit mAb at a dilution of 1:1600 (40x lens). High pressure antigen retrieval was performed with 0.01 M citrate buffer (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15337_rabbit-hla-dr-mab-4y9y8-5220251718983.jpg)
![Immunohistochemistry: HLA-DR Antibody (4Y9Y8) [HLA-DR] - Immunohistochemistry analysis of HLA-DR in paraffin-embedded human liver tissue using HLA-DR Rabbit mAb at a dilution of 1:1600 (40x lens). High pressure antigen retrieval was performed with 0.01 M citrate buffer (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15337_rabbit-hla-dr-mab-4y9y8-52202517251958.jpg)
![Western Blot: HLA DR DP Antibody (MEM-136) [NB500-447] - Fig. 1. Western Blotting analysis of MHC Class II in whole cell lysate of RAJI human Burkitt lymphoma cell line using anti-human HLA-DR+DP (MEM-136). The antibody MEM-136 recognizes beta-chain of HLA-DR antigen under non-reducing conditions. Lane 1: immunostaining with anti-human HLA-DR+DP (MEM-136) Lane 2: immunostaining with Isotype mouse IgG1 control (PPV-06).](http://images.novusbio.com/fullsize/p_2392_1.jpg "Western Blot: HLA DR DP Antibody (MEM-136) [NB500-447] - Fig. 1. Western Blotting analysis of MHC Class II in whole cell lysate of RAJI human Burkitt lymphoma cell line using anti-human HLA-DR+DP (MEM-136). The antibody MEM-136 recognizes beta-chain of HLA-DR antigen under non-reducing conditions. Lane 1: immunostaining with anti-human HLA-DR+DP (MEM-136) Lane 2: immunostaining with Isotype mouse IgG1 control (PPV-06).")
![Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Cynomolgus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD20-Antibody-10F381-rituximab-Chimeric-Flow-Cytometry-NBP2-52646-img0003.jpg "Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Cynomolgus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD20-Antibody-10F381-rituximab-Chimeric-Flow-Cytometry-NBP2-52646-img0001.jpg)
![Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Rhesus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD20-Antibody-10F381-rituximab-Chimeric-Flow-Cytometry-NBP2-52646-img0002.jpg)
![Flow Cytometry: HLA DRA Antibody (169-1B5.2) - Azide and BSA Free [NBP2-47722] - Flow Cytometric Analysis of PFA-fixed Raji cells. HLA DRA Antibody (169-1B5.2) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-169-1B5-2-Azide-and-BSA-Free-Flow-Cytometry-NBP2-47722-img0003.jpg "Flow Cytometry: HLA DRA Antibody (169-1B5.2) - Azide and BSA Free [NBP2-47722] - Flow Cytometric Analysis of PFA-fixed Raji cells. HLA DRA Antibody (169-1B5.2) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).")
![Western Blot: NAT10 Antibody [NBP2-15033] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with NAT10 antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/NAT10-Antibody-Western-Blot-NBP2-15033-img0001.jpg "Western Blot: NAT10 Antibody [NBP2-15033] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with NAT10 antibody diluted at 1:1000.")
![Immunohistochemistry: NAT10 Antibody [NBP2-15033] - Immunohistochemical analysis of paraffin-embedded zebrafish tissue, using NAT10 antibody (NBP2-15033) at 1:300 dilution.](http://images.novusbio.com/fullsize/nbp2-15033_rabbit-polyclonal-nat10-antibody-9102024205678.jpg)
![Western Blot: NAT10 Antibody [NBP2-15033] - Various tissue extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with NAT10 antibody (NBP2-15033) diluted at 1:500.](http://images.novusbio.com/fullsize/nbp2-15033_rabbit-polyclonal-nat10-antibody-91020242021939.jpg)
![Flow Cytometry: HLA DRA Antibody (169-1B5.2) [NBP2-45043] - Flow Cytometric Analysis of PFA-fixed Raji cells. HLA DRA Antibody (169-1B5.2) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-169-1B5-2-Flow-Cytometry-NBP2-45043-img0004.jpg "Flow Cytometry: HLA DRA Antibody (169-1B5.2) [NBP2-45043] - Flow Cytometric Analysis of PFA-fixed Raji cells. HLA DRA Antibody (169-1B5.2) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).")